During the past decade, CEPIC - Centro Paulista de Investigação Clínica conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 17 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CEPIC - Centro Paulista de Investigação Clínica" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Pfizer" with 7 trials sponsored, "BioNTech SE" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Ache Laboratorios Farmaceuticos S.A." with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEPIC - Centro Paulista de Investigação Clínica" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CEPIC - Centro Paulista de Investigação Clínica" are "Obesity" (6 trials), "Arthritis, Rheumatoid" (5 trials), "Overweight" (4 trials), "Rheumatoid Arthritis" (4 trials) and "Type 2 Diabetes" (3 trials). Many other conditions were trialed in "CEPIC - Centro Paulista de Investigação Clínica" in a lesser frequency.

Most popular intervention types in "CEPIC - Centro Paulista de Investigação Clínica" are "Drug" (29 trials), "Biological" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Tirzepatide" (8 trials), "Tocilizumab" (3 trials), "BNT162b2" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "CEPIC - Centro Paulista de Investigação Clínica" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CEPIC - Centro Paulista de Investigação Clínica". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in CEPIC - Centro Paulista de Investigação Clínica, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CEPIC - Centro Paulista de Investigação Clínica, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".